Rhone Ma Holdings Bhd (XKLS:5278) Market Cap: RM152.9 Mil (As of Jul. 07, 2026)


XKLS:5278 Rhone Ma Holdings Bhd XKLS:5278
61 GF Score
Price RM0.69
GF Value RM0.80
Valuation Modestly Undervalued
View Full Analysis

What is Rhone Ma Holdings Bhd Market Cap?

Rhone Ma Holdings Bhd XKLS:5278 61 Market Cap is RM152.9 Mil as of Jul. 07, 2026. GuruFocus rates XKLS:5278 with a GF Score™ of 61/100 and a GF Value™ of RM0.80 (Modestly Undervalued). Among 1,024 Drug Manufacturers companies, Rhone Ma Holdings Bhd ranks worse than 72.17% on this metric.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Rhone Ma Holdings Bhd's share price for the quarter that ended in Mar. 2026 was RM0.68. Rhone Ma Holdings Bhd's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 222.0 Mil. Therefore, Rhone Ma Holdings Bhd's market cap for the quarter that ended in Mar. 2026 was RM151.0 Mil.

Rhone Ma Holdings Bhd's quarterly market cap increased from Sep. 2025 (RM146.4 Mil) to Dec. 2025 (RM151.9 Mil) but then declined from Dec. 2025 (RM151.9 Mil) to Mar. 2026 (RM151.0 Mil).

Rhone Ma Holdings Bhd's annual market cap declined from Dec. 2023 (RM152.6 Mil) to Dec. 2024 (RM149.3 Mil) but then increased from Dec. 2024 (RM149.3 Mil) to Dec. 2025 (RM151.9 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Rhone Ma Holdings Bhd's Enterprise Value for Today is RM132.7 Mil.


Rhone Ma Holdings Bhd  (XKLS:5278) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Rhone Ma Holdings Bhd Market Cap Related Terms


Rhone Ma Holdings Bhd Market Cap Historical Data

* Premium members only.

The historical data trend for Rhone Ma Holdings Bhd's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rhone Ma Holdings Bhd Market Cap Chart

Rhone Ma Holdings Bhd Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 148.64 150.43 152.65 149.33 151.89

Rhone Ma Holdings Bhd Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 146.01 134.95 146.39 151.89 150.97

XKLS:5278 vs ZTS, UTHR, VTRS: Market Cap Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Rhone Ma Holdings Bhd's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rhone Ma Holdings Bhd Market Cap vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Rhone Ma Holdings Bhd's Market Cap distribution charts can be found below:

* The bar in red indicates where Rhone Ma Holdings Bhd's Market Cap falls into.


XKLS:5278
61GF Score
Rhone Ma Holdings Bhd XKLS:5278
Market Cap is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rhone Ma Holdings Bhd Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Rhone Ma Holdings Bhd's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as

Market Cap (A: Dec. 2025 )=Share Price (A: Dec. 2025 )*Shares Outstanding (EOP) (A: Dec. 2025 )
=RM0.69*220.128
=RM151.9

Rhone Ma Holdings Bhd's Market Cap for the quarter that ended in Mar. 2026 is calculated as

Market Cap (Q: Mar. 2026 )=Share Price (Q: Mar. 2026 )*Shares Outstanding (EOP) (Q: Mar. 2026 )
=RM0.68*222.015
=RM151.0

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of RM152.9 Mil mean?
Rhone Ma Holdings Bhd (XKLS:5278) has a Market Cap of RM152.9 Mil as of Jul. 07, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Rhone Ma Holdings Bhd and its competitors. According to the industry distribution chart, Rhone Ma Holdings Bhd ranks #739 out of 1024 companies in the Drug Manufacturers industry, placing it in the top 72.2%.
Is Rhone Ma Holdings Bhd's Market Cap too high?
Rhone Ma Holdings Bhd's current Market Cap is RM152.9 Mil. Based on the distribution chart, Rhone Ma Holdings Bhd ranks #739 out of 1024 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Rhone Ma Holdings Bhd has a GF Score™ of 61/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Rhone Ma Holdings Bhd's Market Cap compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Rhone Ma Holdings Bhd ranks #739 out of 1024 companies for Market Cap. This places Rhone Ma Holdings Bhd in the lower half of its industry. The industry median Market Cap is 220.02. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 220.02, based on 1,024 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Rhone Ma Holdings Bhd and its competitors. For the Drug Manufacturers industry, the median Market Cap is 220.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rhone Ma Holdings Bhd's current Market Cap is RM152.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rhone Ma Holdings Bhd stock overvalued right now?
Based on GuruFocus' analysis, Rhone Ma Holdings Bhd (XKLS:5278) is currently considered Modestly Undervalued. The stock's GF Value™ is RM0.80, compared to a current price of RM0.69 — trading 13.8% below its estimated fair value. The current Market Cap is RM152.9 Mil. Rhone Ma Holdings Bhd's overall GF Score™ is 61/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Rhone Ma Holdings Bhd (XKLS:5278), the current Market Cap is RM152.9 Mil as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Rhone Ma Holdings Bhd (XKLS:5278) Overvalued in 2026?

Based on GuruFocus' analysis, Rhone Ma Holdings Bhd stock appears to be undervalued. The current stock price of RM0.69 is trading 13.8% below its estimated GF Value™ of RM0.80. GuruFocus considers Rhone Ma Holdings Bhd to be Modestly Undervalued.

Key valuation signals for XKLS:5278:

  • Market Cap: RM152.9 Mil
  • GF Value™: RM0.80 vs. price of RM0.69 (13.8% below fair value)
  • GF Score™: 61/100

No single metric tells the full story. See the XKLS:5278 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Rhone Ma Holdings Bhd Business Description

Address Jalan 241, Lot 18A and 18B, Seksyen 51A, Petaling Jaya, SGR, MYS, 46100
Rhone Ma Holdings Bhd, along with its subsidiaries, is mainly involved in the provision of end-to-end animal health solutions. The Group provides veterinary consultation services, diagnostic laboratory analyses, R&D, and is engaged in the manufacturing and distribution of animal health products. Its reportable segments are: Animal health products and equipment, Food ingredients, and Others. The majority of its revenue is generated from the Animal health products and equipment segment, which is engaged in marketing, trading, distribution, and manufacturing of animal health products and equipment, such as pharmaceuticals, vaccines, feed additives, pesticides, and others. Geographically, the Group's operations are predominantly located in Malaysia.
61GF Score

Get the complete analysis for XKLS:5278

Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM0.69
Price
RM0.80
GF Value